Alcon Inc. vs Eli Lilly & Co.
ALC vs LLY — side-by-side comparison from reported financials. ALC leads 4, LLY leads 7 of 11 comparable metrics.
Alcon Inc.
ALC · Healthcare
$64.11+1.55%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ALC | LLY |
|---|---|---|
| Price | $64.11 | $1 177.20 |
| Market cap | $31.0B | $1.05T |
| Revenue (TTM) | $10.4B | $79.7B |
| Revenue growth | +6.1% | +31.7% |
| Net margin | 9.4% | 33.5% |
| Free cash flow | $1.74B | $18.2B |
| Net cash (debt) | ($3.84B) | ($35.2B) |
| 1-year price return | -14.0% | +37.6% |
| P/E | 38.4 | 41.6 |
| P/E vs own history (cheap-side %) | 99% | 88% |
| Dividend yield | 0.55% | 0.52% |
| Return on equity | 3% | 93% |
| Altman Z-score | 2.56 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 25,942 | 50,000 |
Full résumé-style profiles: ALC CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.